Reducing ICU Delirium with Dexmedetomidine Sleep
Official title: Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
Run by Massachusetts General Hospital · NCT06192615 · Data updated 2026-11-12
This study is testing if a sleep-inducing medication called dexmedetomidine can help older patients recover better and avoid confusion after heart surgery in the ICU.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 1800 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 14 sites (Los Angeles, California and 13 other locations) |
| Status | Recruiting |
| Started | January 6, 2025 |
| Main results expected | October 31, 2027 |
| Study ends | March 31, 2029 |
| Registry record updated | September 14, 2026 |
| Trial ID | NCT06192615 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are elderly patients aged 60 years or older who are scheduled for cardiac surgery requiring cardiopulmonary bypass and will be admitted to the ICU postoperatively.
✕Probably not a fit
Patients with preexisting cognitive impairments, severe liver failure, or those undergoing procedures requiring total circulatory arrest may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This phase III clinical trial evaluates the effects of intravenous and sublingual dexmedetomidine on postoperative delirium and functional outcomes in elderly patients following cardiac surgery. It employs a randomized, blinded, double placebo-controlled design with three arms to compare the efficacy of dexmedetomidine against placebo. The study aims to determine whether inducing sleep with dexmedetomidine can minimize neurological dysfunction in the ICU setting.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of delirium in elderly patients after cardiac surgery, leading to improved recovery and functional outcomes.
How similar studies have gone: Previous studies have shown promising results with dexmedetomidine in reducing delirium, suggesting that this approach may be effective, although this specific methodology is being tested in a novel context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 60 years or older * Scheduled to undergo a cardiac surgical procedure with cardiopulmonary bypass * Planned postoperative admission to the intensive care unit (ICU) Exclusion Criteria: * Allergy or hypersensitivity to dexmedetomidine or the placebo study medication * Preexisting diagnosis of Alzheimer's Disease or Related Dementia, severe cognitive impairment or delirium at baseline * Severe liver failure (Child-Pugh score \> 5) * Severe deficit(s) due to structural or anoxic brain damage * Undergoing a surgical procedure requiring total circulatory arrest * SARS-CoV-2 positive or symptomatic (e.g., fever, cough, loss of taste/smell) * Blind, deaf, or unable to communicate in English * Patients experiencing circumstances for which long-term follow-up might be difficult (e.g., homelessness, active psychotic disorder, or substance abuse) * Co-enrollment in other interventional studies that, in the opinion of the site investigator and/or PI, might interfere with study participation, collection, or interpretation of the study data
Where it's running
-
University of California San Francisco
San Francisco, California, United States Recruiting -
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States Recruiting -
University of Iowa Carver College of Medicine
Iowa City, Iowa, United States Recruiting -
University of Maryland School of Medicine
Baltimore, Maryland, United States Recruiting -
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting -
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States Recruiting
Show 8 more locations
-
Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting -
Washington University School of Medicine
St Louis, Missouri, United States Recruiting -
University of Nebraska Medical Center
Omaha, Nebraska, United States Recruiting -
Columbia University Medical Center
New York, New York, United States Recruiting -
Montefiore Medical Center
The Bronx, New York, United States Recruiting -
Duke University Hospital
Durham, North Carolina, United States Recruiting -
Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting -
Cedars-Sinai Medical Center
Los Angeles, California, United States Not yet recruiting
Study contacts
- Principal investigator: Oluwaseun Johnson-Akeju, MD — Massachusetts General Hospital
- Study coordinator: Oluwaseun Johnson-Akeju, MD
- Email: ojohnsonakeju@partners.org
- Phone: 617-726-3030
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can citicoline help prevent cognitive decline after delirium in older adults with hip fracture?
This study tests whether taking citicoline for 6 months after discharge helps prevent cognitive decline in adults 65 and older who had delirium during hospitalization for hip fracture.
-
Delirium and Light: Exploring Modifiable Risk Factors in Critically Ill Adults
This pilot observational study tests whether circadian-light factors influence delirium risk in adults recovering in critical care.
-
VR-based cognitive games to help prevent delirium after big surgery
A VR-based cognitive stimulation game is being tested to see if it can help prevent delirium in adults 65 and older after major surgery.
-
Computer-assisted cognitive stimulation for delirium in older adults
This will try adding tablet-based cognitive exercises to sleep and mobility support to see if they reduce delirium in people aged 60 and older in subacute care.
-
Letting patients drink clear fluids until called to the operating room to shorten pre-surgery fasting
This project will try letting elective procedure patients drink clear liquids until they're called to the operating room to see if fasting times, comfort, and perioperative outcomes improve.
-
Lemborexant to help Sleep and Delirium in older ICU patients
This study tests whether lemborexant, a sleep medication, helps improve sleep and reduce delirium in adults 65 and older in the ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.